Considerations on the off-label use of ketamine as a treatment for mood disordersPharmacy Today, American Pharmacists Association, pharmacist.comSanacora and Wilkinson point to a consensus statement that was released, in the absence of long-term safety and efficacy studies, by the American Psychiatric Association Council of Research Task Force on Novel Biomarkers and Treatments. The document ...